BioLineRx Ltd.
(BLRX)
undefined
undefined%
At close: undefined
0.23
0.84%
After-hours Dec 13, 2024, 06:59 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
Revenue | 4.80M | - | - | - | - | - | - | - | - | - | 113.16M | 113.16M | 63.91M | 31.89M |
Cost of Revenue | 3.69M | 654.00K | 702.00K | 934.00K | 940.00K | 451.00K | 480.68K | 481.89K | 440.89K | - | - | - | 22.62M | 7.21M |
Gross Profit | 1.11M | -654.00K | -702.00K | -934.00K | -940.00K | -451.00K | -480.68K | -481.89K | -440.89K | - | 113.16M | 113.16M | 41.29M | 24.69M |
Operating Income | -49.69M | -29.16M | -24.78M | -22.93M | -28.11M | -25.61M | -25.24M | -16.51M | -16.20M | -15.85M | -17.63M | -21.83M | -15.41M | 3.70M |
Interest Income | 2.01M | 694.00K | 559.00K | 236.00K | 777.00K | 719.00K | 1.17M | 480.00K | 457.00K | 3.28M | 746.59K | 2.36M | 3.34M | 861.33K |
Pretax Income | -60.61M | -24.95M | -27.05M | -30.02M | -25.45M | -22.96M | -24.35M | -15.84M | -14.40M | -10.17M | -17.64M | -20.42M | 61.52M | 2.10M |
Net Income | -60.61M | -18.87M | -28.14M | -30.93M | -26.81M | -18.51M | -24.35M | -15.84M | -14.40M | -10.17M | -17.64M | -20.42M | -13.19M | 2.10M |
Selling & General & Admin | 31.23M | 11.53M | 5.27M | 4.68M | 4.59M | 5.77M | 5.73M | 5.31M | 4.65M | 4.95M | 4.86M | 4.57M | 4.21M | 5.44M |
Research & Development | 12.52M | 17.63M | 19.47M | 18.17M | 23.44M | 19.81M | 19.51M | 11.18M | 11.49M | 10.90M | 12.65M | 17.21M | 11.20M | 15.49M |
Other Expenses | 7.05M | 5.67M | 42.00K | 70.00K | 78.00K | 27.00K | -260.00K | 7.00K | 153.00K | 2.81M | -280.83K | -322.27K | 0.00 | 50.17K |
Operating Expenses | 50.80M | 29.16M | 24.78M | 22.93M | 28.11M | 25.61M | 25.24M | 16.51M | 16.20M | 15.85M | 17.63M | 21.83M | 15.41M | 20.98M |
Interest Expense | 2.17M | 2.16M | 984.00K | 1.47M | 1.83M | 21.00K | 21.00K | 14.00K | 15.00K | 411.67K | 20.67K | 25.96K | 1.12M | 16.63K |
Selling & Marketing Expenses | 14.59M | 6.46M | 1.00M | 840.00K | 857.00K | 1.36M | 1.69M | 1.35M | 1.00M | 1.46M | 1.18M | 863.77K | 869.15K | 1.30M |
Cost & Expenses | 54.49M | 29.16M | 24.78M | 22.93M | 28.11M | 25.61M | 25.24M | 16.51M | 16.20M | 15.85M | 17.63M | 21.83M | 15.41M | 28.19M |
Income Tax | 1K | -6.08M | 1.09M | 911.00K | 1.36M | -4.46M | -888.00K | -672.00K | -1.80M | -5.68M | 15.79K | -1.42M | -2.22M | 1.61M |
Shares Outstanding (Basic) | 64.22M | 51.60M | 44.20M | 16.86M | 9.76M | 7.24M | 6.00M | 3.74M | 3.43M | 2.16M | 1.50M | 1.13M | 823.91K | 823.41K |
Shares Outstanding (Diluted) | 64.22M | 51.60M | 44.20M | 16.86M | 9.76M | 7.24M | 6.00M | 3.74M | 3.43M | 2.16M | 1.50M | 1.13M | 823.91K | 830.31K |
EPS (Basic) | -0.94 | -0.37 | -0.64 | -1.84 | -2.75 | -2.56 | -4.06 | -4.23 | -4.2 | -4.71 | -11.77 | -18.08 | -16 | 2.54 |
EPS (Diluted) | -0.94 | -0.37 | -0.64 | -1.84 | -2.75 | -2.56 | -4.06 | -4.23 | -4.2 | -4.71 | -11.77 | -18.08 | -16 | 2.54 |
EBITDA | -57.06M | -28.50M | -25.35M | -21.99M | -27.17M | -25.15M | -23.83M | -15.34M | -13.94M | -10.79M | -16.70M | -19.38M | -13.59M | 4.21M |
Depreciation & Amortization | 1.38M | 654.00K | 702.00K | 934.00K | 940.00K | 451.00K | 480.68K | 481.89K | 441.00K | 246.54K | 329.36K | 407.93K | 410.67K | 511.27K |